November 15, 2021, 09.18 PM


JAKARTA, KOMPAS.com – Oral Covid-19 antiviral medicine Molnupiravir produced by U.S. drugmaker Merck is expected to arrive in Indonesia end of this year, the country’s top health official said.

Health Minister Budi Gunadi Sadikin said that the pharmaceutical is still waiting for the U.S. Food and Drug Administration (FDA) to grant emergency use authorization to its covid-19 antiviral pill.

“We expect that Molnupiravir to arrive in Indonesia by the end of the year and we will use it for next year,” Budi told a press conference on Monday, November 15.

Also readCovid-19 Antiviral Pill Plant to be Developed in Indonesia, Senior Minister Says

He hoped that the FDA will authorize the emergency use of Molnupiravir in early December. The ministry will also study other Covid-19 antiviral treatments.

“We are collaborating with the country’s Food and Drug Monitoring Agency (BPOM) to study other Covid-19 antiviral medicine that can reduce the risk of hospital admission for treating people who have Covid-19,” the minister said.

It was previously reported that Indonesia would buy 600,000 to one million Molnupiravir pills, which are claimed to be the Covid-19 antiviral treatment, produced by Merck.

The collaboration was initially discussed during his recent visit to the United States. The plan to buy the Covid-19 antiviral treatment was disclosed by Budi during his working meeting with members of the House of Representatives Commission IX last week. At the meeting, he explained that the purchase was made to anticipate a surge in Covid-19 cases following the year-end holiday.

(Writer: Haryanti Puspa Sari | Editor: Dani Prabowo)

Source: https://nasional.kompas.com/read/2021/11/15/17082581/menkes-obat-molnupiravir-siap-digunakan-tahun-depan.

 

 

Dapatkan update berita pilihan dan breaking news setiap hari dari Kompas.com. Mari bergabung di Grup Telegram "Kompas.com News Update", caranya klik link https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.



Latest Video

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
September 30, 2022, 07.14 PM

Indonesia Approves First Homegrown Covid-19 Vaccine

News
September 29, 2022, 09.40 PM

Indonesia, Singapore to Intensify Marine Patrols

News
September 26, 2022, 06.21 PM

Six People Killed in Philippine Typhoon

Business
September 20, 2022, 10.22 PM

EU Hopes for Trade Pact with Indonesia within Two Years

Close Ads